Skip to content

FSS To Showcase Rebrand and New Controlled Substances at ASHP MIDYEAR, 2019

FDA Registered 503B Outsourcing Facility

News

FSS To Showcase Rebrand and New Controlled Substances at ASHP MIDYEAR, 2019

ASHP 2019 Conference with Fagron Sterile Services

Fagron Sterile Services US (FSS) is excited to join pharmaceutical vendors, suppliers and practitioners from across the world in support of health-system pharmacists at one of the largest pharmacy conferences in the United States, December 8 – 12, 2019. The American Society of Health-System Pharmacists (ASHP) is planning a “Bigger. Brighter. MIDYEAR” for 2019. FSS…

Read More

Fall ’19 Holiday Shipping

Holiday Shipping Schedule At Fagron Sterile Services, our customers and their patients’ safety are a top priority. So with the holiday season approaching, please take a moment to review our shipping schedule (below). To ensure appropriate supply for you and your patients, please plan ahead and order accordingly to avoid a drug shortage at your…

Read More

JCB Laboratories and Fagron Sterile Services Secure Group Purchasing Organization Contract With Premier Inc.

Fagron Sterile Services

GPO Awards 503B Human Drug Compounding Outsourcing Contract for Ophthalmics to Fagron Wichita, KS – June 20, 2017 – JCB Laboratories (JCB) and Fagron Sterile Services (FSS), companies of Fagron North America, announced they have been awarded a contract with Premier Inc., a leading healthcare improvement company which operates one of the nation’s largest Group…

Read More

ProPharma

In January, JCB registered with the FDA as an 503B Outsourcing Facility. This registration indicates our commitment to patient safety and acknowledges that a higher level of compliance and oversight is welcomed. We also understand that in order to continue providing sterile compounded products to facilities across the country, it was necessary to align our…

Read More

FDA and State Registration for Outsourcing Facilities

The passing of the Drug Quality and Security Act (DQSA) in November of 2013 was one of the most significant events in the compounding industry in decades. The DQSA came to fruition after many months of debate and controversy over who had authority and jurisdiction over sterile compounding pharmacies. The result was that a sterile…

Read More

Fagron Acquisition of JCB Laboratories to Reshape U.S. Sterile Compounding Industry

New $15 million drug outsourcing facility largest capital project in Fagron’s history MIAMI – Fagron North America, a leading supplier of compounded medications to hospital pharmacies and patients, will open one of the largest 503B human drug outsourcing facilities in the U.S. in November utilizing automation not yet seen in the nation’s sterile compounding industry.…

Read More

Pre-Op Combination Ophthalmic Drops

Previously we have posted blogs about combining ophthalmic drops for pre-operative use in cataract surgeries and YAG laser procedures. See the two blogs below. 3 Options to Meet USP 797 Requirements for Combination Ophthalmic Dilating Drops Calculating the Final Concentration for Combination Ophthalmic Drops Compounded ophthalmic products are a specialty at JCB and we routinely…

Read More

Disney and Amerinet – A Great Combination

The Group Purchasing Organization, Amerinet, had a member conference in May and it was a tremendous success. The only thing better than the venue at the Dolphin in Disney World were the people. The Amerinet representatives did their usual stellar job of connecting suppliers with customers and the members were extremely gracious with their time…

Read More
Scroll To Top